SEC Form 4/A · accession 0001209191-16-153188
ImmunityBio, Inc. · IBRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
John C Thomas
Director
Period of report
Nov 22, 2016
Accepted (ET)
Dec 2, 2016 · 9:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326110
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 23, 2016 | S | 7,719 | $7.50 | D | 315,070 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This amendment is filed to include 719 shares sold by the reporting person on November 23, 2016. These 719 shares were incorrectly included in the amount of shares beneficially owned by the reporting person in a subsequent Form 4 filed November 29, 2016.